TriSalus Life Sciences (NASDAQ: TLSI)
$4.77
(1.3%)
$0.06
Price as of July 17, 2025, 3:58 p.m. ET
TriSalus Life Sciences Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
TriSalus Life Sciences Company Info
TriSalus Life Sciences, Inc. is an oncology company, which engages in the business of integrating standard-of-care treatments and investigational immunotherapeutic with disruptive pressure enabled drug delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. The firm is also involved in developing an innovative organ-specific platform that prevents optimal delivery and performance of immunotherapeutics in difficult-to-treat diseases. The company is headquartered in Westminster, CO.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.